Status:
COMPLETED
Nasopharyngeal Streptococcus Pneumoniae Carriage
Lead Sponsor:
Pfizer
Conditions:
Streptococcus Pneumoniae Infections
Eligibility:
All Genders
2-5 years
Brief Summary
Primary Objective: Evaluation of the \- Carriage rate of Streptococcus pneumoniae in the nasopharynx of children Secondary Objective: * Carriage rate and distribution of Streptococcus pneumoniae se...
Eligibility Criteria
Inclusion
- Children aged between 2 months and 5 years attending pediatric clinics in hospitals, day care centers or kindergartens.
- Informed consent obtained from parents or legal guardian.
Exclusion
- Children younger than 2 months of age.
- Children with following serious diseases: immunological disease, neoplastic disease, renal, cardiac or hematological disease, bronchodysplasia, Down's syndrome.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
9707 Patients enrolled
Trial Details
Trial ID
NCT00471822
Start Date
July 1 2005
End Date
December 1 2010
Last Update
November 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Taoyuan District, Taiwan, 333